New funding opportunities for membersJune 5, 2020
New funding opportunities for members
Covid-19 Specific Funding
UKRI open call for research and innovation ideas to address Covid-19. There is no closing date
UK Research and Innovation (UKRI) will support excellent proposals of up to 18 months duration which meet at least one of the following: a) New research or innovation with a clear impact pathway that has the potential (within the period of the award) to deliver a significant contribution to the understanding of, and response to, the Covid-19 pandemic and its impacts. b) Supports the manufacture and/or wide scale adoption of an intervention with significant potential. c) Gathers critical data and resources quickly for future research use. For more information click here.
National Institute for Health Research: Travel and subsistence funding to support LMIC engagement during the Covid-19 outbreak. Deadline 31 December 2020
The awards will provide travel and subsistence funding to appropriately qualified public health professionals, clinicians and academics who wish to offer science and technical advice to support the immediate response to Covid-19 in low and middle-income countries. The awards are open to applicants who have a substantive position at a UK higher education institution or research organisation. For more information click here.
Fast Funding for Covid-19 Science. Deadline: 31 December 2020.
A new venture fund is offering grants of $10,000 to $500,000 to coronavirus researchers, and every grant decision will be made in less than 48 hours. For more information click here.
Covid-19 Rapid Response Rolling Call. Deadline: 1 April 2021
Building on the initial calls of their Initiative, DHSC, through the NIHR, and UKRI are jointly launching a rolling call for proposals for rapid research into Covid-19. As this is a rolling call there is currently no fixed end date to the call, we are open to applications and will aim to review complete proposals within four weeks of submission. This is a researcher-led call: for UK-led academic, SME and wider industry research that will address a wide range of Covid-19 knowledge gaps/needs, and which will lead to a benefit in UK, potentially international, public health within 12 months. For more information click here.
New Future Fund To Support Innovative UK Businesses
The Chancellor of the Exchequer today announced he is to establish a new Future Fund to support the UK’s innovative businesses currently affected by Covid-19. These businesses have been unable to access other government business support programmes, such as CBILS, because they are either pre-revenue or pre-profit and typically rely on equity investment. The scheme will deliver an initial commitment of £250m of new government funding which will be unlocked by private investment on a match funded basis. The government scheme, which will be developed in partnership with the British Business Bank with the intention of launching for applications in May, will initially be open until the end of September. Over the coming weeks the Bank will work with government on the details on how the Future Fund will operate and how to apply for the scheme. For more information click here.
Bill & Melinda Gates Foundation, Wellcome & Mastercard Covid-19 Therapeutics Accelerator.
The Bill & Melinda Gates Foundation, Wellcome, and Mastercard have committed up to $125 million in seed funding to speed-up the response to the Covid-19 epidemic by identifying, assessing, developing, and scaling-up treatments. The partners are committed to equitable access, including making products available and affordable in low-resource settings. The Covid-19 Therapeutics Accelerator will play a catalytic role by accelerating and evaluating new and repurposed drugs and biologics to treat patients with Covid-19 in the immediate term, and other viral pathogens in the longer-term. Currently there are no broad-spectrum antivirals or immunotherapies available for the fight against emerging pathogens, and none approved for use on Covid-19. For more information click here.
Other Featured Funding
Eureka: healthy ageing. Deadline: 5 August 2020
UK registered businesses can apply for a share of up to £2 million to develop digital health technologies in partnership with organisations from EUREKA countries. For more information click here.
ISCF Healthy Ageing Social, Behavioural & Design Research Programme. Pre-announcement
UK Research and Innovation (UKRI) will be inviting applications to the ISCF Healthy Ageing Social Behavioural and Design Research Programme from May 2020. £9.5m (100% fEC) will be available to support world-leading research that makes a significant contribution to the lives of people as they age. For more information click here.
OTHER FUNDING OPPORTUNITIES:
Innovation Scholars secondments: biomedical sciences, strands 2-3. Deadline:1 July 2020.
UKRI invites applications for individuals from any discipline wishing to spend up to 36 months (full or part time) on secondment in the biomedical sciences sector. £5 million fund. For more information click here.
For more information on all open IUK funding opportunities click here.
DEFENCE AND SECURITY ACCELERATOR (DASA):
DASA: Biosensing across wide areas. Deadline: 1 June 2020
DASA is looking for solutions to detect and locate deposited hazardous biological agents rapidly in the field. Proposals will need to deliver a higher level of maturity than achieved in Phase 1. We expect the starting Technology Readiness Level (TRL) of the innovation to be TRL 3. By the end of the project, we expect the innovation to be sufficiently developed to achieve approximately TRL 4 – 5. £700k is available to fund Phase 2. For more information click here.
Open Competition: rolling deadline.
The Open Call is one of the funding competition mechanisms DASA uses to find proposals that address challenges faced by government stakeholders. It gives bidders the opportunity to present their ideas to defence and security stakeholders at any time, without waiting for a relevant Themed Competition. Click here to find out more.
For more information on all DSTL – DASA funding opportunities click here.
NATIONAL INSTITUTE FOR HEALTH RESEARCH (NIHR):
NIHR: I4I Product Development Award Round 20. Deadline: 3 June 2020.
The NIHR Invention for Innovation (i4i) programme will invite proposals to Call 20 of its researcher-led Product Development Awards (PDA). PDAs fund the development of disruptive early stage medical technologies that address existing or emerging healthcare needs. They support translational projects developing medical devices, active implantable devices and in vitro diagnostic devices. PDAs also support projects that use and develop techniques or technologies from other industry sectors that could have a potential impact if applied in a healthcare setting. For more information click here.
NIHR: I4I Challenge Awards on Real World Implementation (RWI). Deadline: 5 June 2020.
The RWI Challenge Award will fund investigations of medtech innovations in healthcare settings. The aim is to shorten the evidence gap between the safety/efficacy typical of a newly or nearly CE marked technology and what is required for decisions by commissioners and regulators. At the same time, this will de-risk the product for follow-on investment. For more information click here.
ECONOMIC AND SOCIAL RESEARCH COUNCIL (ESRC): Research Grants. Deadline: Open call.
If you have an excellent idea for a research project, the EPSRC have their Research Grants open call. Awards ranging from £350,000 to £1 million (100 per cent full Economic Cost (fEC)) can be made to eligible institutions to enable individuals or research teams to undertake anything from a standard research project through to a large-scale survey and other infrastructure or methodological development. Click here to find out more.
ENGINEERING AND PHYSICAL SCIENCES RESEARCH COUNCIL (EPSRC):
The EPSRC is the main funding body for engineering and physical research sciences. For EPSRC funding opportunities click here.
MEDICAL RESEARCH COUNCIL (MRC)
The Medical Research Council (MRC) improves the health of people in the UK – and around the world – by supporting excellent science, and training the very best scientists.
For MRC funding opportunities click here.
TRUSTS AND CHARITIES:
Association of Medical Research Charities
Over 30 years ago a small, diverse group of medical research charities form the Association of Medical Research Charities (AMRC) to unite the sector and provide it with a leading voice. Since then their membership has grown to over 140 charities. In 2018, these charities invested £1.3 billion in medical research. To access their database click here.
OTHER UK GOVERNMENT, SEED FUNDS AND LOANS:
THE BRITISH BUSINESS BANK: Deadline: Open.
BBB are a government-owned business development bank dedicated to making finance markets work better for smaller businesses. Whether you’re looking for finance to start a business, grow to the next level, or stay ahead of the competition, they say that they can deliver greater volume and choice of finance. For more information click here.
UK Innovation & Science Seed Fund. Open.
The UK Innovation & Science Seed Fund (formerly known as The Rainbow Seed Fund) is a £27.1m early-stage venture capital fund building and growing technology companies stemming from the UK’s research base. For more information click here.
Creative England Investments. Deadline: open.
Creative England is supporting SMEs by providing competitive loans to digital businesses in order to make their growth plans a reality. The investments on offer are intended to fuel this fast-growing sector by financing business expansion and new products, leading to the creation of new high-quality jobs and Intellectual Property (IP). Loans from £50,000 – £250,000 are available with repayment terms ranging from 3-36 months. Interest rates range from 5% – 10%, depending on the risk profile of the applicant. This includes companies from within the digital healthcare sector. For more information click here.
HSBC Loan Fund. Open.
HSBC UK has announced a £12 billion lending fund to support the UK’s small and medium-sized enterprises (SMEs). The Fund includes a ring-fenced £1 billion to help UK companies grow their business overseas, as well as a broader package of support. The initiative is available to UK businesses with a turnover of up to £350 million. Applicants do not need to be an HSBC customer to apply. For more information click here.
The Global Challenges Research Fund. Click here to find out more.
The Newton Fund. Click here to find out more.
European Funding. Click here to find out more.
Grants available to UK through US Defense – medical research program Click here to find out more.
Export Opportunities – To access the Department of International Trades Export Opportunities Pipeline click here.
Find out how to get your study nationally supported or funded as high priority Covid-19 Urgent Public Health Research
Covid-19 Urgent Public Health Research is being prioritised to gather the necessary clinical and epidemiological evidence that will inform national policy and enable new diagnostic tests, treatments and vaccines to be developed and tested for Covid-19. Government support is available to prioritise, coordinate and deliver these studies, regardless of sponsorship and funding source. This support includes expedited identification of sites to ensure appropriate geographical distribution of Urgent Public Health Research to maximise recruitment and minimise over-commitment of resource. Find out more by clicking here.
New findings from Innovate UK show that half of young people in the UK think their age is a barrier to business success. The programme will support up to 100 young people, with £5K funding, one-to-one coaching and an allowance to cover living costs. The national Young Innovators Awards will go to 18-30 year olds with a creative and ground-breaking business idea. For more information click here.
Also coming soon:
Healthy Ageing Challenge
UKRI is working with the National Academy of Medicine (NAM) in the USA as a Global Collaborator in their Healthy Longevity Grand Challenge. They will commission a set of Catalyst Awards to support early stage innovation and stimulate interest in global opportunities.
Collaborative R&D Competition:
The aim of the Collaborative R&D competition is to focus on the high-potential early stage collaborative projects, which address key opportunities that would not otherwise be eligible for funding under the Trailblazer nor the Investment Accelerator programmes.